Table 5.

Differences between the dose delivered using the nominal tissue I-value and ±5% and ±10% the nominal value for different volume levels (95% and 10%) and the mean dose for prostate patient.

Target Volumes
		−10%	−5%	+5%	+10%
GTV	95% Volume	1.8%	0.9%	−0.8%	−1.5%
	10% Volume	1.7%	0.9%	−0.7%	−1.5%
	Mean	1.2%	0.7%	−0.9%	−1.5%
CTV	95% Volume	1.6%	0.9%	−0.8%	−1.5%
	10% Volume	1.7%	0.9%	−0.7%	−1.5%
	Mean	1.4%	0.8%	−0.6%	−1.4%
PTV	95% Volume	1.7%	0.8%	−0.8%	−1.5%
	10% Volume	1.7%	0.9%	−0.8%	−1.6%
	Mean	1.6%	0.9%	−0.6%	−1.2%
Organs at Risk
		−10%	−5%	+5%	+10%
Ant Rectum	10% Volume	1.6%	0.6%	−1.0%	−1.6%
	Mean	1.0%	0.5%	−1.7%	−2.7%
Post Rectum	10% Volume	2.0%	1.8%	0.6%	−1.9%
	Mean	1.0%	0.2%	−0.9%	−1.2%
Whole Rectum	10% Volume	1.0%	1.1%	−0.2%	−1.6%
	Mean	1.8%	0.9%	−0.8%	−1.3%
Bladder	10% Volume	1.0%	0.5%	−0.6%	−1.3%
	Mean	1.1%	0.5%	−0.7%	−1.3%
L Femoral Head	10% Volume	1.8%	0.9%	−0.7%	−1.4%
	Mean	1.7%	0.8%	−1.1%	−2.2%
R Femoral Head	10% Volume	1.8%	0.9%	−0.9%	−1.5%
	Mean	2.5%	1.0%	−1.0%	−1.8%